Liver transplantation for children - The Red Cross Children's Hospital experience

Pediatric Transplantation

Volumn 8, Issue 2, 2004, Pages 136-144

  Millar, A J W ^a   Spearman, W ^a   McCulloch, M ^a   Goddard, E ^a   Raad, J ^a   Rode, H ^a   Kahn, D ^a   Cywes, S ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Children; Cytomegalovirus; Epstein Barr virus; Hepatitis B; Human immunodeficiency virus; Liver transplantation; South Africa; Tuberculosis

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; AMPHOTERICIN B; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; BASILIXIMAB; COTRIMOXAZOLE; CYCLOSPORIN A; DACLIZUMAB; ENALAPRIL; ETHAMBUTOL; ETHIONAMIDE; GANCICLOVIR; HEPATITIS B CORE ANTIGEN; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; OFLOXACIN; OMEPRAZOLE; RIFAMPICIN; SUCRALFATE; TACROLIMUS; TUBERCULOSTATIC AGENT;

ADOLESCENT; ARTICLE; BILE DUCT ATRESIA; CHILD; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DEVELOPING COUNTRY; EPSTEIN BARR VIRUS; FEMALE; GRAFT REJECTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; HYPERTENSION; INFANT; KIDNEY FUNCTION; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TOXICITY; LIVER TRANSPLANTATION; LIVER WEIGHT; LONG TERM CARE; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MYCOSIS; NEPHROTOXICITY; ORGAN DONOR; PATIENT COMPLIANCE; PEDIATRIC HOSPITAL; PEDIATRICS; PNEUMOCYSTOSIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PROPHYLAXIS; QUALITY OF LIFE; SCREENING; STATISTICAL ANALYSIS; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; THROMBOSIS; TUBERCULOSIS; VIRUS INFECTION;

ACTUARIAL ANALYSIS; ADOLESCENT; ANTIVIRAL AGENTS; BILIARY ATRESIA; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GANCICLOVIR; HOSPITALS, PEDIATRIC; HUMANS; INFANT; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; OPPORTUNISTIC INFECTIONS; ORGAN SIZE; PATIENT COMPLIANCE; RED CROSS; SOUTH AFRICA; SURVIVAL ANALYSIS; TISSUE DONORS; WAITING LISTS;

EID: 1942487301     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1399-3046.2003.00131.x     Document Type: Article

References (51)

1. ROBSON SC, SPEARMAN CW, JAMES MF et al. Orthotopic liver transplantation at Groote Schuur Hospital. S Afr Med J 1992: 82: 79-82.
2. LLOYD-STILL JD. Impact of liver transplantation on mortality from pediatric liver disease. J Pediatr Gastroenterol Nutr 1991: 12: 305-309.
3. WHITINGTON PF, BALISTRERI WF. Liver transplantation in pediatrics: indications, contraindications and pretransplant management. J Pediatr 1991: 118: 169-177.
4. STARZL TE, DEMETRIS AJ, VAN THIEL D. Medical progress: liver transplantation part I. N Engl J Med 1989: 321: 1014-1022.
5. STARZL TE, DEMETRIS AJ, VAN THIEL D. Medical progress: liver transplantation part II. N Engl J Med 1989: 321: 1092-1099.
6. National Institute of Health Consensus. National Institute of Health Consensus Development Conference Statement: Liver Transplantation 20-23 June 1983. Hepatology 1984: 4(Suppl. 1): 107S-110S.
7. PARADIS KJG, FREESE DK, SHARP HI. A pediatric perspective on liver transplantation. Pediatric Clin N Am 1988: 35: 409-433.
8. BALISTRERI WF. Transplantation for childhood liver disease. An overview. Liver Transpl Surg 1998: 4: 518-523.
9. TAN KC, MONDRAGON RS, VORGAS V et al. Liver transplantation for fuliminant hepatic failure and late-onset hepatic failure in children. Br J Surg 1992: 79: 1192-1194.
10. KELLY DA. Nutritional factors affecting growth before and after liver transplantation. Pediatr Transplant 1997: 1: 80-84
11. BISMUTH H, HOUSSIN D. Reduced size orthotopic liver graft in hepatic transplantation in children. Surgery 1984: 95: 367-370.
12. EMOND JC, HEFFRON TG, WHITINGTON PF, BROELSCH CE. Reconstruction of the hepatic vein in reduced size hepatic transplantation. Surg Gynaecol Obstetr 1993: 176: 11-17.
13. STRONG R, ONG TH, PILLAY P et al. A new method of segmented orthotopic liver transplantation in children. Surgery 1988: 104: 104-107.
14. CHAPIN JW, NEWLAND MC, HURLBERT BJ. Anesthesia for liver transplantation. Semin Liver Dis 1989: 9: 195-201.
15. DAVIS PJ, COOK DR. Anesthetic problems in pediatric liver transplantation. Transplant Proc 1989: 21: 3493-3496.
16. JORDAN SC, ROSENTHAL P, MAKOWKA L. Immunosuppression in organ transplantation. Semin Pediatr Surg 1993: 2: 206-217.
17. PARROTT, NR. Immunosuppression: the old and the new. In FORSYTHE JLR, ed. Transplantation Surgery, Chapter 5. Philadelphia, PA: WB Saunders Company Ltd., pp. 89-121.
18. KLINTMALM G. US Multicenter FK506 Liver Study Group: a comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. New Eng J Med 1994: 381: 1110-1115.
19. HOVER PF. Cyclosporin A (Neoral) in paediatric organ transplantation. Pediatr Tranplant 1998: 2: 35-39.
20. GANSCHON R, BROERING DE, STUERENBERG I, REGIERS X, HELWEGE HR, BURDELSKI M. First experience with basiliximabl in pediatric liver graft recipients. Pediatr Transpl 2001: 5: 357-358.
21. FISHMAN JA, RUBIN RH. Infection in Organ-Transplant recipients. N Engl J Med 1998; 338: 1741-1751.
22. DEEN JL, BLUMBERG DA. Infectious Disease Considerations in Pediatric Organ Transplantation. Semin Pediatr Surg 1993: 2: 218-234.
23. WINSTON DJ, WIRIN D, SHAKED A, BUSUTTIL W. Randomised comparison of gancyclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients. Lancet 1995: 346: 69-74.
24. MORGAN G, SUPERINA RA. Lymphoproliferative disease after pediatric liver transplantation. J Pediatr Surg 1994: 29: 1192-1196.
25. MC DAIRMID SV, JORDAN S, LEE GS et al. Prevention and pre-emptive therapy of post-transplant lympopmif erative disease in pediatric liver recipients. Transplantation 1998: 66: 1604-1611.
26. Fujisawa Ltd. Prograf Data Sheet. London: Fujisawa Ltd., 1995.
27. Sandoz Pharmaceuticals (UK) Ltd. Neoral Data Sheet Survey. UK: Sandoz Pharmaceuticals, 1995.
28. YANDZA T, GAUTHIER F, VALAYER J. Lessons from the first 100 liver transplantations in infants and children at Biiëtre Hospital. J Pediatr Surg 1994: 29: 905-911.
29. DEMETRIS AJ, BATTS KP, DILLON AP et al. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997: 25: 658-663.
30. NOBLE-JAMIESON BARNES N. Diagnosis and management of late complications after liver transplantation. Arch Dis Child 1999: 81: 446-451.
31. PHILLIPS JO, METZLER MH, PALMIERI TL et al. A prospective study of simplified omeprazole suspension for the prophylaxis of stress related mucosal damage. Crit Care Med 1996: 24: 1793-1800.
32. MILLAR AJW, SPEARMAN W, MC CULLOCH M et al. Paediatric liver transplantation in a developing country - taking stock. Pediatr Transplant 2000; 4: 129.
33. SPEARMAN CWN, MC CULLOCH M, MLLAR AJW et al. Posttransplant lymphoproliferative disease (PLTD) in paediatric liver transplant recipients in a developing country. Pediatr Transplant 2000: 4: 53.
34. GODDARD EA, MILLAR AJW, SPEARMAN CWN, MC CULLOCH MI, KAHN D. Cytomegalovirus (CMV) infection in paediatric liver transplant recipients in a developing country. Pediatr Transplant 2000: 4: 48.
35. DICKSON RC, EVERHARTT JE, LAKE JR et al. The National Institute of diabetes and digestive and kidney diseases liver transplantation database transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. Gastroenterology 1997: 113: 1668-1674.
36. RAYES N, NEUHAUS R, NAUMANN U et al. Treatment of hepatitis B reinfection or de novo infection after liver transplantation with famiciclovir - how effective is it. Transplant Proc 1998: 31: 481-482.
37. GRELLIER L, MOTIMER D, AHMED M et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 1996: 348: 1212-1215.
38. WAYMAN KI, COX KL, ESQUIREL CO. Neurodevelopmental outcome of young children with extrahepatic biliary atresia 1 year after liver transplantation. J Pediatr 1997: 131: 894-898
39. GOSI JA, SCHACKLETON CR, MC DAIRMID SV et al. Long-term results of paediatric liver transplantation. Ann Surg 1998: 228: 411-420.
40. MIGLIAZZA L, LOPEZ SANTAMARIA M, MURCIA J et al. Long-term survival expectancy after liver transplantation in children. J Pediatr Surg 2000: 35: 5-8.
41. SOKAL EM, VEYCKEMANS F, DE VILLE DE GOYET J et al. Liver transplantation in children less than I year of age. J Pediatr 117: 2: 205-210.
42. STEWART SM, UAUY R, WALLER DA et al. Mental and motor development. Social competence and growth one year after successful pediatric liver transplantation. J Pediatr 1989: 114: 574-581.
43. MEYERS BR, HALPERN M, SHEINER P et al. Tuberculosis in liver transplant patients. Transplantation 1994: 58: 301-306.
44. OTTE JB, DE VILLE DE GOYET J, SOKAL EM et al. Size reduction of the donor liver is a safe way to alleviate the shortage of size-matched organs in pediatric liver transplantation. Ann Surg 1990; 211: 146-157.
45. BROELSCH CN, STEVENS LH, WHITINGTON PF. The use of reduced-size liver transplants in children, including split livers and living related transplants. Eur J Pediatr Surg 1991; 1: 166-171.
46. SINGER PA, SIEGLER M, WHITINGTON PF et al. Ethics of liver transplantation with living donors. N Engl J Med 1989: 321: 620-622.
47. EMRE S. Living-donor liver transplantation in children. Pediatr Transplant 2002; 6: 43-46.
48. COLOMBANI PM, LAU H, PRAKHAKARAN K et al. Cumulative experience with pediatric living related liver transplantation. J Pediatr Surg 2000; 35: 9-12.
49. REYES G, GERBER D, MAZARIEGOS GV et al. Split-liver transplantation: a comparison of ex vivo and in situ techniques. J Pediatr Surg 2000; 35: 283-290.
50. TESTA G, MALAGO M, BROELSCH CE. From living related to in-situ split liver transplantation: how to reduce waiting-list mortality. Pediatr Transplant 2001; 5: 16-20.
51. SHEPHERD RW. Liver transplantation in children. Med J Aust 1990; 153: 509-510.